Product Information
ALISKIREN 300 MG TABLET is a generic product labeled by Endo USA Inc., priced at $5.7183 per EA under NDC 49884042511. Its NADAC has been published 379 times since May 22, 2019.
FDA first approved this application on Mar 22, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Endo USA Inc.NDC
49884042511
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ALISKIREN HEMIFUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA206665FDA Approved
3/22/2019
TE Code
AB
On Market Since
3/25/2019
Pharmacological Classes
Price Statistics
The NADAC for ALISKIREN 300 MG TABLET has been published 379 times since May 22, 2019, and over the history we have for it it has declined 23.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.7183 per EA |
|---|---|
| All-time high | $7.7118 (May 12, 2021) |
| All-time low | $4.4638 (Jun 19, 2024) |
| 52-week high | $5.7183 |
| 52-week low | $5.0380 |
| Median price | $6.4788 |
| Average price | $6.3572 |
| Largest weekly change | +26.9% (Jun 17, 2020) |
| Weeks tracked | 379 |
| Tracking since | May 22, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ALISKIREN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ALISKIREN 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALISKIREN 300 MG TABLET, manufactured by Endo USA Inc., is $5.7183 per EA (NDC 49884042511), effective Aug 19, 2026.
How has the price of ALISKIREN 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALISKIREN 300 MG TABLET has declined 23.4%. It has been tracked across 379 weekly CMS publications since May 22, 2019.
What are the highest and lowest recorded NADAC prices for ALISKIREN 300 MG TABLET?
Since May 22, 2019, the NADAC for ALISKIREN 300 MG TABLET has ranged from a low of $4.4638 (Jun 19, 2024) to a high of $7.7118 (May 12, 2021), with a median of $6.4788 per EA.
Are there cheaper alternatives to ALISKIREN 300 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ALISKIREN 300 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ALISKIREN 300 MG TABLET?
ALISKIREN 300 MG TABLET (NDC 49884042511) is labeled by Endo USA Inc., and CMS classifies it as a generic product.